Five things to know:
1. Fourth-quarter sales of $1.9 billion are a 6.3% increase year over year.
2. Knee sales in the fourth quarter were $798.3 million, a 5.9% year-over-year increase. Hip sales were $504.8 million, up 3.3%.
3. Sports medicine, extremities, trauma, craniomaxillofacial and thoracic sales were $453.3 million in the fourth quarter, up 6.9%.
4. Zimmer Biomet’s full-year sales for 2023 hit $7.4 billion, up 6.5% from 2022 sales.
5. The company expects a 4.5% to 5.5% increase in sales in 2024.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
